Biotech is one of the most potentially lucrative yet endlessly frustrating market sectors.
Last year was particularly annoying. There were a couple big wins in the space, but the entire industry has been kneecapped for a few reasons…
But all of that is in the rearview mirror now – and with that narrative getting priced in, it’s time to start looking at biotech as a viable space again…
And BridgeBio (BBIO) is leading the way.
In early January I noticed two things:
First, BBIO was trading near its range highs while the rest of the biotech space was getting clobbered.
That told me there was a “strange bid” in the stock that required further digging.
Second, the chart had built out a Point of Control (POC) at the upper end of that range. That tells me there is some urgency in the name and if the stock managed to clear above it, it was going to push higher.
That’s why I alerted our paid clients to purchase the stock at $29.38, and we’re up a quick 15% in a week.
I also recommended the Jul $40 call option, which is trading as I write this at $3.45. When we alerted our clients, it was trading at $2.00, so that’s a 72.5% gain in the same time period – and I’m expecting more after this pullback finishes.
Of course, biotech is only one sector we’re exploiting with this POC strategy…
Did you know about this contrarian trade? No? Let’s talk about solar then.
The sector’s been an absolute dog, falling 35% in 2024:
There are economic and political reasons for the abysmal performance.
For one, the Biden administration removed tariffs on panels coming out of Southeast Asia…
And then China pulled the end around by shipping all their panels to Vietnam, which absolutely flooded the U.S. market.
Now we have the Trump regime coming in, which is bullish as hell for traditional energy plays and even nuclear…
But the emerging narrative around solar is that it's as good as dead.
It’s true that some solar startups relied too heavily on government subsidies.
And institutions have been a net seller of solar stocks.
But I believe we’re nearing the bottom – and one key signal is lighting up BIG time in this beaten down sector…
Corporate insiders – CEOs, CFOs, directors, board members – know more about the health and future prospects of their companies than anyone else...
And they’ve been buying up solar stocks like crazy.
Take a look…
A director at Sunrun Inc (RUN) scooped up 10,000 shares back in March:
Two high-level executives – the president and the CEO – went in for more than 20,000 shares at Array Technologies (ARRY):
Multiple officers including the CEO of FTC Solar (FTCI) have been loading the boat all year long:
And here’s SolarEdge Technologies (SEDG), which has seen massive insider buying in 2024:
The CFO purchased more than $157,000 worth of stock back in August…
A director made two purchases totaling more than $595,000 in November…
And another director accumulated more than $3.6 MILLION in stock over three purchases starting back in February and as recently as November.
I’m keeping a close eye on all these names heading into 2025…
As well as a handful of other stocks with triple-digit profit potential that insiders are loading the boat with right now.
If you’d like to learn more about how these insiders reveal opportunities like 470%, 627%, and 1,105%, click here to access a free training video where I show you the SEC rule that makes it all possible – and the details of our top three picks right now.
I’ve talked here before about my love of space flight, Star Trek, and all things science…
But as a kid reading Popular Science magazine, I never imagined those interests would lead to profitable opportunities in the stock market.
But that’s exactly the case with IonQ (IONQ), a quantum computing company on the cutting edge of the last true tech frontier.
I give more detail in the video above, but the long and short of it is we detected an early warning signal in this stock back in early October when it was trading around $9.60.
This week, it traded as high as $44.50…
A 363% stock gain in just two months.
Our call options did even better. Buying just 10 contracts at our recommended entry would have cost you around $740…
And today, you could have been sitting on a total (realized and unrealized) win of around $11,500.
Check out the video above for the full trade details…
Today’s video is a little… different.
In just under 12 minutes, I’m covering MicroStrategy, Bitcoin, volatility, the VIX, SPACs, and warrants…
And then I’m going to tie it all together with my “grand unifying theory.”
Highlights include:
Give it a watch…
When I was little, my dad had a pet Gila monster.
We lived in Tucson, and very regularly the Gila monster would slither up the back porch and snack on some tasty treats we’d left for him.
It was a completely stupid idea, and potentially illegal. Gila monsters are venomous and shouldn’t be handled.
But there’s something really interesting about their venom.
It has something called exendin-4, which helps the Gila monster regulate its blood sugar.
Scientists discovered this mechanism in the ‘90s. They isolated the chemical and found it works very similarly to something called “glucagon-like-peptide-1.”
You may know that by its more common name: GLP-1.
GLP-1 agonists mimic the peptide, which causes your body to work better with blood sugar. That’s why it was approved for Type 2 diabetes.
Then they found that it’s really effective for helping people lose weight. Liraglutide was approved in 2014, and then semaglutide was approved in 2021.
Ely Lilly (LLY) and Novo Nordisk (NVO) were the big winners:
They saw 300-400% gains after that catalyst.
Now, I’m a self-admitted nerd. I was biohacking way before it was cool or trendy.
I’ve known about peptides for a long time. And I can tell you, if you’re only looking at Ozempic and Wegovy, you’re already behind the 8-ball.
Drugs like BPC157 or MK-677 are making their way into the mainstream, and they’ve been around a long, long time.
But I’ve just stumbled on a little pharma company that’s working on drugs that could be the next wave of Wegovies and Ozempics.
I explain more in the video above…
Take a look, and then click here to learn more about the early warning signal that tipped me off to this opportunity – plus three others I’m monitoring right now.
I live in Florida, not far from a U.S. Air Force test range.
That means we get every type of fighter jet you can think of flying directly over our house.
F-4 Phantoms… F-14 Tomcats… F-22 Raptors… F-35 Lightnings…
F-22 Raptor
We even see V-22 Ospreys every once in a while.
Now, I absolutely love fighter jets. I love the way they look, the way they sound, and I love imagining how much fun it must be to fly one.
… but I understand they’re big and expensive, and that the nature of war is changing.
If we’ve learned anything from the war in Ukraine, it’s that drones are completely reshaping the face of war.
According to Reuters, thousands of drones have been deployed to track enemy forces, guide artillery targets, and deliver payloads deep inside enemy lines.
The trend is clear…
The only problem is the U.S. has not yet contracted with a drone manufacturer. The leading company right now is DJI – a privately held Chinese tech firm.
What that means, though, is there’s a major market opportunity for a U.S. company.
There are a few drone plays out there right now.
One is AeroVironment (AVAV), which is more of a drone defense play:
Draganfly (DPRO) has been around for a while, but the stock hasn’t done particularly well. The company just went through a reverse stock split, and could be ready for a push higher from here:
The new kid on the block is Unusual Machines, ticker UMAC.
After its IPO, this stock wasn’t doing much of anything… until it recently went parabolic:
As I record this, the stock is in a squeeze and could continue even higher…
But what if you could have been warned ahead of this move?
There were actually three distinct signals you could have followed into this stock before it soared more than 550%...
There’s no doubt Nvidia (NVDA) will go down as one of the most successful tech stories of the 21st century.
For two years, we’ve watched them smash earnings expectations again… and again… and again.
At this point, though, the trade is running out of steam. It’s reaching its peak. After all, it’s a $3.5 trillion stock. That means it would take another trillion-plus of market capitalization just to get another 30% bump in the share price!
But, naturally, people are going to be distracted by Nvidia for months – possibly years – to come. More savvy market participants are moving into semiconductors… but they’re barking up the wrong tree, too.
My take? The trade to focus on is the one no one wants to touch…
Like it or not, Donald Trump is heading back to the White House. And this time around, he has the judicial and legislative leverage to accomplish a lot of his agenda…
And at the top of that list is taking a chainsaw to regulation. That’s going to open up a lot of possibilities…
For instance, rare earth minerals could be in play, as could agriculture stocks.
But the area that’s really piquing my interest is oil services – and my top ticker there is OIH, an oil services ETF.
The companies in this fund don’t pull oil out of the ground, but they get paid by those who do…
Because if you’re going to “drill, baby, drill,” well, you’re going to have to buy the drills from someone.
The sector has underperformed since 2005. There are a lot of reasons for that… but there’s been a recent trend change, and I’ll be watching this ticker closely heading into 2025. Some other names in this sector to keep an eye on include Diamond Offshore Drilling (DO) and Transocean (RIG).
There’s more to the energy story, too. As you probably know, the power demands being generated by AI are absolutely unsustainable without alternative solutions – including nuclear.
Energy Fuels (UUUU) is a uranium stock I’ve been watching for a while, and it looks to be setting up for a potential breakout. Another tangential AI play I like right now is Lumen (LUMN), a Louisiana firm that provides fiber and power connections to AI companies.
These are just some of the investing themes and opportunities I’m excited about as 2025 approaches. And the best part is I have an advantage that 99% of other investors don’t – one that has helped us find recent wins of 366%, 510%, and 683%...
Click here and I’ll tell you all about it in a video presentation.
It’s official.
The long winter for Bitcoin is over.
America’s first “pro-blockchain” Presidential candidate was elected, and now it’s game on.
I don’t think this can be emphasized enough.
The President-Elect owns millions in crypto and has launched multiple blockchain projects. His staff is going to be full of pro-crypto participants, and we’re going to have the mainstream moment as a “preference cascade” hits and Boomers end up getting on-chain.
It’s not just the price breakout, either. It’s the removal of Gary Gensler from the SEC. It’s the end of the harassment and Wells notices of emerging financial institutions. Projects and companies will be able to raise capital faster.
The vibes are real.
One of our favorite plays in the crypto space is Core Scientific (CORZ).
The stock is hitting new all time highs as crypto pushes higher, and I think it is just getting started.
This is an exceptionally well run company. When many crypto companies seem to be run by a bunch of clowns, CORZ has competent operators with a clear vision.
And they’re buying like crazy.
This chart shows the number of insiders that have purchased CORZ stock over the past year. What’s unusual about this is CORZ is a recent IPO– normally corporate insiders are net sellers as they get liquid and cash out.
Yet these insiders are taking the opposite approach, getting more concentrated in their positions. Maybe they know something?
Post-IPO insider buys are rare, and you should pay attention when they happen. My best recent example of this is in KGS, where insiders were picking up more shares shortly after the company was listed:
The stock is up 80% from those buys, and we followed right along. I think CORZ is set up for a similar run.
I’ve got three other stocks seeing similar insider buying. I talked about them in detail in a recent interview – you can check it out right here.
